Back
Altisource Portfolio Solutions SA Vs. Nektar Therapeutics Industry Stock Comparison
Buy
53
ASPS
Altisource Portfolio Solutions SA
Last Price:
$12.63
Seasonality Move:
9.74%
Buy
56
NKTR
Nektar Therapeutics
Last Price:
$24.96
Seasonality Move:
3.38%
Buy
53
Altisource Portfolio Solutions SA (ASPS)
is a Buy
Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?
-
The current Altisource Portfolio Solutions SA [ASPS] share price is $12.61. The Score for ASPS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
ASPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $25.01. The Score for NKTR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASPS Stock Price Chart
What is Altisource Portfolio Solutions SA's stock price today?
-
The Altisource Portfolio Solutions SA share price today is $12.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASPS is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $25.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
ASPS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.27 | Buy |
Relative Strength Index (14 RSI): | 67.94 | Buy |
Chaikin Money Flow: | -32838 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.75 - 11.45) | Buy |
Bollinger Bands (100): | (5.48 - 9) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 65.9 | Buy |
Chaikin Money Flow: | -64604 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.5 - 25.8) | Buy |
Bollinger Bands (100): | (7.55 - 17.95) | Buy |
ASPS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.28 | Buy |
20-day SMA: | 10.21 | Buy |
50-day SMA: | 8.21 | Buy |
200-day SMA: | 7.21 | Buy |
8-day EMA: | 11.71 | Buy |
20-day EMA: | 10.29 | Buy |
50-day EMA: | 8.76 | Buy |
200-day EMA: | 8.77 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.32 | Buy |
20-day SMA: | 19.57 | Buy |
50-day SMA: | 14.05 | Buy |
200-day SMA: | 14.55 | Buy |
8-day EMA: | 15.41 | Buy |
20-day EMA: | 7.97 | Buy |
50-day EMA: | 3.56 | Buy |
200-day EMA: | 0.94 | Buy |
Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.
Altisource Portfolio Solutions SA Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |